In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusatium spp.

被引：64

作者：

Philip, A ^{[1
]}

Odabasi, Z ^{[1
]}

Rodriguez, J ^{[1
]}

Paetznick, VL ^{[1
]}

Chen, E ^{[1
]}

Rex, JH ^{[1
]}

Ostrosky-Zeichner, L ^{[1
]}

机构：

[1] Univ Texas, Sch Med, Div Infect Dis, Lab Mycol Res, Houston, TX 77030 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 08期

关键词：

D O I：

10.1128/AAC.49.8.3572-3574.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro interactions of anidulafungin with itraconazole, voriconazole, and amphotericin B were evaluated by using the checkerboard method. For Aspergillus spp., anidulafungin with amphotericin B showed indifference for 16/26 isolates, while anidulafungin with either azole showed a synergy trend for 18/26 isolates. All drug combinations showed indifference for 7/7 Fusarium sp. isolates.

引用

页码：3572 / 3574

页数：3

共 20 条

[1]

American Society for Microbiology, 2004, ANTIMICROB AGENTS CH, V48, pi

[2]

[Anonymous], CLIN INFECT DIS

[3]

[Anonymous], 2002, M27A2 CLSI

[4] In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :245-247

[5] Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by national committee for clinical laboratory standards methods M27-A and M38-P [J].

Carrillo-Muñoz, AJ ;

Ruesga, M ;

Brio, S ;

del Valle, O ;

Rodriguez, V ;

Santos, P ;

Hernández-Molina, JM ;

Cantón, E ;

Pemán, J ;

Guarro, J ;

Quindós, G .

CHEMOTHERAPY, 2002, 48 (05) :224-231

[6] The first echinocandin: caspofungin [J].

Cornely, OA ;

Schmitz, K ;

Aisenbrey, S .

MYCOSES, 2002, 45 :56-60

[7] Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis [J].

Denning, DW ;

Ribaud, P ;

Milpied, N ;

Caillot, D ;

Herbrecht, R ;

Thiel, E ;

Haas, A ;

Ruhnke, M ;

Lode, H .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :563-571

[8] Introduction to antifungal drugs [J].

Dismukes, WE .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :653-657

[9] EXPERIMENTAL APPROACH TO THE PROBLEM OF TREATMENT FAILURE WITH PENICILLIN .1. GROUP-A STREPTOCOCCAL INFECTION IN MICE [J].

EAGLE, H .

AMERICAN JOURNAL OF MEDICINE, 1952, 13 (04) :389-399

[10] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

← 1 2 →